BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2020

Jul 1, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2020-04-30

Reporting Person: Mueller Brian (EVP, Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-04-30	Common Stock	A	323	$62.586	Acquired	25104	Direct
2020-06-29	Common Stock	A	4640	—	Acquired	29744	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-29	Stock Option (Right to buy Common Stock)	$122.18	A	13230	Acquired	2030-06-28	Common Stock (13230)	Direct

Footnotes

F1: Represents shares acquired by the reporting person on April 30, 2020, pursuant to the issuer's Employee Stock Purchase Plan.

F2: Restricted stock units granted on June 29, 2020. Price not applicable.

F3: Option grant vests 12/48th on June 29, 2021 and 1/48th on the 29th day of each month thereafter.